StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Gross-to-Net Revenue Deductions Provision by Year

Gross-to-Net Revenue Deductions Provision ($M)

Novartis Gross-to-Net Revenue Deductions Provision: $7,809M in FY2025, up 11.5% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
7,809
Period ended Dec 31, 2025
Change on a year earlier
+11.5%
7,004 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Includes Medicaid rebates, Medicare Part D, 340B Drug Pricing Program, PBM commercial rebates, wholesaler chargebacks, and sales returns.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGross-to-Net Revenue Deductions Provision ($M)Year on yearSource
FY2025Dec 31, 20257,809+11.5%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 20247,004+10.9%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 20236,315-6.2%Novartis Form 20-F (0001114448-26-000004) ↗
FY2022Dec 31, 20226,732+3.9%Novartis Form 20-F (0001114448-26-000004) ↗
FY2021Dec 31, 20216,481+3.6%Novartis Form 20-F (0001370368-25-000004) ↗
FY2020Dec 31, 20206,256+11.8%Novartis Form 20-F (0001370368-24-000004) ↗
FY2019Dec 31, 20195,595+6.3%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2018Dec 31, 20185,262+12.6%Novartis Form 20-F (0001370368-22-000010) ↗
FY2017Dec 31, 20174,672+11.7%Novartis Form 20-F (0001370368-21-000006) ↗
FY2016Dec 31, 20164,183+10.4%Novartis Form 20-F (0001370368-20-000003) ↗
FY2015Dec 31, 20153,790–Novartis Form 20-F (0001370368-19-000002) ↗

Breakdown

What makes up gross-to-Net Revenue Deductions Provision

Cite this data

StockData. (2026). Novartis Gross-to-Net Revenue Deductions Provision ($M), annual FY2015–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/gtn-ending-provision

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.